Precision NanoSystems

Precision NanoSystems Inc. is a Canadian biotechnology company based in Vancouver, British Columbia. The company was co-founded by Pieter Cullis, who also co-founded Acuitas Therapeutics.[1] His co-founders are Euan Ramsay and James Taylor.

The company develops genetic medicine-based therapies, including “self-assembling” molecules that carry drugs and gene therapies directly into the cells of the human body using DNA and RNA encapsulated in lipid nanoparticles.[2][3] It was launched with assistance from Genome British Columbia.[4]

History

Precision NanoSystems was founded in 2010 by Pieter Cullis, Euan Ramsay and James Taylor.[1:1][5]

COVID-19

The COVID-19 Vaccine Task Force considered a proposal from Precision NanoSystems on June 22, 2020.[6]

Representatives from Precision NanoSystems met with the Government of Canada's COVID-19 Joint Biomanufacturing Subcommittee on July 6 and 10, 2020, to discuss a "biomanufacturing project."[7]

On October 23, 2020, Canadian Prime Minister Justin Trudeau announced that he had awarded the company $18.2 million from the Government of Canada to develop an RNA vaccine for COVID-19.[8] The funding came from Innovation, Science and Economic Development Canada’s Strategic Innovation Fund (SIF), which focuses on supporting private sector-led vaccine and therapy clinical trials.

The company was acquired by Danaher on June 1, 2021.[5:1]

In July 2022, Replicate Bioscience issued a press release announcing a partnership with Precision NanoSystems to “accelerate the creation, scale-up, and delivery of self-replicating RNA (srRNA) therapies.”[9]

Investors

Investors in Precision NanoSystems include:[10]

  • 5AM Ventures
  • Accel-Rx
  • Northview LifeSciences
  • Rising Tide
  • Telegraph Hill Partners

  1. Cullis, P. (2019, June 25). Innovation as a Driver for Personalized Medicine in British Columbia. Reboot Communications. https://web.archive.org/web/20210713174744/https://www.rebootcommunications.com/wp-content/uploads/2019/06/Cullis-Kelowna-June-2019.pdf ↩︎ ↩︎

  2. Create Transformative Medicines. Precision NanoSystems. Retrieved March 8, 2022, from http://archive.today/2021.07.24-200212/https://www.precisionnanosystems.com/ ↩︎

  3. Shore, R. (2016, February 25). Vancouver-Based Nanomedicine Startup Targets Genetic Solution to Diseases. Precision NanoSystems. http://archive.today/2022.03.09-051358/https://www.precisionnanosystems.com/news-room/detail/vancouver-based-nanomedicine-startup-targets-genetic-solution-diseases ↩︎

  4. Annual Report 2020-2021. Genome BC. Retrieved April 18, 2022, from https://web.archive.org/web/20210703114654/https://www.genomebc.ca/wp-content/uploads/2021/06/GBC-5198-2020-21-AR-FINAL_WEB.pdf ↩︎

  5. Precision NanoSystem - Crunchbase Company Profile & Funding. Crunchbase. Retrieved February 7, 2023, from https://www.crunchbase.com/organization/precision-nanosystem ↩︎ ↩︎

  6. COVID-19 Vaccine Task Force Registry of Interests. (2023, March 27). Innovation, Science and Economic Development Canada. http://archive.today/2023.07.09-180656/https://ised-isde.canada.ca/site/biomanufacturing/en/covid-19-vaccine-task-force/covid-19-vaccine-task-force-registry-interests ↩︎

  7. Innovation, Science and Economic Development Canada. (2022, July 7). COVID-19 Joint Biomanufacturing Subcommittee. Government of Canada. http://archive.today/2024.04.30-223848/https://ised-isde.canada.ca/site/biomanufacturing/en/covid-19-vaccine-task-force/covid-19-joint-biomanufacturing-subcommittee ↩︎

  8. Precision NanoSystems. (2020, October 26). Prime Minister announces LSI spinoff to receive funding to develop an RNA Vaccine for COVID-19 | Life Sciences Institute. University of British Columbia. https://lsi.ubc.ca/2020/10/26/prime-minister-announces-lsi-spinoff-to-receive-funding-to-develop-rna-vaccine-for-covid-19/ ↩︎

  9. Replicate Bioscience. (2022, July 26). Precision NanoSystems and Replicate Bioscience in licensing deal to scale up genomic medicines. Cision Newswire. https://web.archive.org/web/20230207015748/https://www.newswire.ca/news-releases/precision-nanosystems-and-replicate-bioscience-in-licensing-deal-to-scale-up-genomic-medicines-888682943.html ↩︎

  10. Precision NanoSystem - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved February 7, 2023, from https://www.crunchbase.com/organization/precision-nanosystem/company_financials ↩︎

About the author
Liam Sturgess

Liam Sturgess

Liam Sturgess is a Canadian writer, researcher and investigative reporter focused on issues of human rights and civil liberties, with a particular interest in the COVID-19 pandemic. He is the founder of White Rose Intelligence.

Knowledge is Freedom

Research and intelligence in defense of liberty

White Rose Intelligence

Great! You’ve successfully signed up.

Welcome back! You've successfully signed in.

You've successfully subscribed to White Rose Intelligence.

Success! Check your email for magic link to sign-in.

Success! Your billing info has been updated.

Your billing was not updated.